UniProt ID | SHIP2_MOUSE | |
---|---|---|
UniProt AC | Q6P549 | |
Protein Name | Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 | |
Gene Name | Inppl1 | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 1257 | |
Subcellular Localization |
Cytoplasm, cytosol. Cytoplasm, cytoskeleton. Membrane Peripheral membrane protein. Cell projection, filopodium. Cell projection, lamellipodium. Translocates to membrane ruffles when activated, translocation is probably due to different mechanisms de |
|
Protein Description | Phosphatidylinositol (PtdIns) phosphatase that specifically hydrolyzes the 5-phosphate of phosphatidylinositol-3,4,5-trisphosphate (PtdIns(3,4,5)P3) to produce PtdIns(3,4)P2, thereby negatively regulating the PI3K (phosphoinositide 3-kinase) pathways. Plays a central role in regulation of PI3K-dependent insulin signaling, although the precise molecular mechanisms and signaling pathways remain unclear. While overexpression reduces both insulin-stimulated MAP kinase and Akt activation, its absence does not affect insulin signaling or GLUT4 trafficking. Confers resistance to dietary obesity. May act by regulating AKT2, but not AKT1, phosphorylation at the plasma membrane. Part of a signaling pathway that regulates actin cytoskeleton remodeling. Required for the maintenance and dynamic remodeling of actin structures as well as in endocytosis, having a major impact on ligand-induced EGFR internalization and degradation. Participates in regulation of cortical and submembraneous actin by hydrolyzing PtdIns(3,4,5)P3 thereby regulating membrane ruffling (By similarity). Regulates cell adhesion and cell spreading. Required for HGF-mediated lamellipodium formation, cell scattering and spreading. Acts as a negative regulator of EPHA2 receptor endocytosis by inhibiting via PI3K-dependent Rac1 activation. Acts as a regulator of neuritogenesis by regulating PtdIns(3,4,5)P3 level and is required to form an initial protrusive pattern, and later, maintain proper neurite outgrowth. Acts as a negative regulator of the FC-gamma-RIIA receptor (FCGR2A). Mediates signaling from the FC-gamma-RIIB receptor (FCGR2B), playing a central role in terminating signal transduction from activating immune/hematopoietic cell receptor systems. Involved in EGF signaling pathway. Upon stimulation by EGF, it is recruited by EGFR and dephosphorylates PtdIns(3,4,5)P3. Plays a negative role in regulating the PI3K-PKB pathway, possibly by inhibiting PKB activity. Down-regulates Fc-gamma-R-mediated phagocytosis in macrophages independently of INPP5D/SHIP1. In macrophages, down-regulates NF-kappa-B-dependent gene transcription by regulating macrophage colony-stimulating factor (M-CSF)-induced signaling. May also hydrolyze PtdIns(1,3,4,5)P4, and could thus affect the levels of the higher inositol polyphosphates like InsP6. Involved in endochondral ossification (By similarity).. | |
Protein Sequence | MASVCGTPSPGGALGSPAPAWYHRDLSRAAAEELLARAGRDGSFLVRDSESVAGAFALCVLYQKHVHTYRILPDGEDFLAVQTSQGVPVRRFQTLGELIGLYAQPNQGLVCALLLPVEGEREPDPPDDRDASDVEDEKPPLPPRSGSTSISAPVGPSSPLPTPETPTTPAAESTPNGLSTVSHEYLKGSYGLDLEAVRGGASNLPHLTRTLVTSCRRLHSEVDKVLSGLEILSKVFDQQSSPMVTRLLQQQSLPQTGEQELESLVLKLSVLKDFLSGIQKKALKALQDMSSTAPPAPLQPSIRKAKTIPVQAFEVKLDVTLGDLTKIGKSQKFTLSVDVEGGRLVLLRRQRDSQEDWTTFTHDRIRQLIKSQRVQNKLGVVFEKEKDRTQRKDFIFVSARKREAFCQLLQLMKNRHSKQDEPDMISVFIGTWNMGSVPPPKNVTSWFTSKGLGKALDEVTVTIPHDIYVFGTQENSVGDREWLDLLRGGLKELTDLDYRPIAMQSLWNIKVAVLVKPEHENRISHVSTSSVKTGIANTLGNKGAVGVSFMFNGTSFGFVNCHLTSGNEKTTRRNQNYLDILRLLSLGDRQLSAFDISLRFTHLFWFGDLNYRLDMDIQEILNYISRREFEPLLRVDQLNLEREKHKVFLRFSEEEISFPPTYRYERGSRDTYAWHKQKPTGVRTNVPSWCDRILWKSYPETHIICNSYGCTDDIVTSDHSPVFGTFEVGVTSQFISKKGLSKTSDQAYIEFESIEAIVKTASRTKFFIEFYSTCLEEYKKSFENDAQSSDNINFLKVQWSSRQLPTLKPILADIEYLQDQHLLLTVKSMDGYESYGECVVALKSMIGSTAQQFLTFLSHRGEETGNIRGSMKVRVPTERLGTRERLYEWISIDKDDTGAKSKVPSVSRGSQEHRSGSRKPASTETSCPLSKLFEEPEKPPPTGRPPAPPRAVPREEPLNPRLKSEGTSEQEGVAAPPPKNSFNNPAYYVLEGVPHQLLPLEPPSLARAPLPPATKNKVAITVPAPQLGRHRTPRVGEGSSSDEDSGGTLPPPDFPPPPLPDSAIFLPPNLDPLSMPVVRGRSGGEARGPPPPKAHPRPPLPPGTSPASTFLGEVASGDDRSCSVLQMAKTLSEVDYAPGPGRSALLPNPLELQPPRGPSDYGRPLSFPPPRIRESIQEDLAEEAPCPQGGRASGLGEAGMGAWLRAIGLERYEEGLVHNGWDDLEFLSDITEEDLEEAGVQDPAHKRLLLDTLQLSK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
3 | Phosphorylation | -----MASVCGTPSP -----CCCCCCCCCC | 29.78 | 26745281 | |
7 | Phosphorylation | -MASVCGTPSPGGAL -CCCCCCCCCCCCCC | 18.57 | 26745281 | |
9 | Phosphorylation | ASVCGTPSPGGALGS CCCCCCCCCCCCCCC | 35.69 | 26745281 | |
16 | Phosphorylation | SPGGALGSPAPAWYH CCCCCCCCCCCHHHC | 20.81 | 23984901 | |
43 | Phosphorylation | ARAGRDGSFLVRDSE HHCCCCCCEEECCCC | 21.50 | 29176673 | |
132 | Phosphorylation | PPDDRDASDVEDEKP CCCCCCHHHCCCCCC | 46.61 | 25521595 | |
145 | Phosphorylation | KPPLPPRSGSTSISA CCCCCCCCCCCEEEC | 42.75 | 26643407 | |
147 | Phosphorylation | PLPPRSGSTSISAPV CCCCCCCCCEEECCC | 21.89 | 26643407 | |
148 | Phosphorylation | LPPRSGSTSISAPVG CCCCCCCCEEECCCC | 33.34 | 26643407 | |
149 | Phosphorylation | PPRSGSTSISAPVGP CCCCCCCEEECCCCC | 19.08 | 26643407 | |
151 | Phosphorylation | RSGSTSISAPVGPSS CCCCCEEECCCCCCC | 26.70 | 26643407 | |
157 | Phosphorylation | ISAPVGPSSPLPTPE EECCCCCCCCCCCCC | 38.36 | 26643407 | |
158 | Phosphorylation | SAPVGPSSPLPTPET ECCCCCCCCCCCCCC | 33.32 | 26643407 | |
162 | Phosphorylation | GPSSPLPTPETPTTP CCCCCCCCCCCCCCC | 41.25 | 26643407 | |
165 | Phosphorylation | SPLPTPETPTTPAAE CCCCCCCCCCCCCCC | 27.43 | 26643407 | |
167 | Phosphorylation | LPTPETPTTPAAEST CCCCCCCCCCCCCCC | 53.48 | 26643407 | |
168 | Phosphorylation | PTPETPTTPAAESTP CCCCCCCCCCCCCCC | 16.48 | 26643407 | |
173 | Phosphorylation | PTTPAAESTPNGLST CCCCCCCCCCCCCCC | 44.42 | 25777480 | |
174 | Phosphorylation | TTPAAESTPNGLSTV CCCCCCCCCCCCCCC | 16.57 | 25777480 | |
179 | Phosphorylation | ESTPNGLSTVSHEYL CCCCCCCCCCCHHHH | 28.32 | 25777480 | |
180 | Phosphorylation | STPNGLSTVSHEYLK CCCCCCCCCCHHHHC | 30.94 | 25777480 | |
182 | Phosphorylation | PNGLSTVSHEYLKGS CCCCCCCCHHHHCCC | 15.64 | 25777480 | |
185 | Phosphorylation | LSTVSHEYLKGSYGL CCCCCHHHHCCCCCC | 14.32 | 25777480 | |
189 | Phosphorylation | SHEYLKGSYGLDLEA CHHHHCCCCCCCHHH | 17.91 | 25367039 | |
190 | Phosphorylation | HEYLKGSYGLDLEAV HHHHCCCCCCCHHHH | 30.31 | 25367039 | |
220 | Phosphorylation | TSCRRLHSEVDKVLS HHHHHHHHHHHHHHH | 43.86 | 30387612 | |
240 | Phosphorylation | SKVFDQQSSPMVTRL HHHHCCCCCHHHHHH | 30.67 | 30635358 | |
241 | Phosphorylation | KVFDQQSSPMVTRLL HHHCCCCCHHHHHHH | 16.81 | 25521595 | |
245 | Phosphorylation | QQSSPMVTRLLQQQS CCCCHHHHHHHHHCC | 14.89 | 30635358 | |
252 | Phosphorylation | TRLLQQQSLPQTGEQ HHHHHHCCCCCCCHH | 37.36 | 27841257 | |
290 | Phosphorylation | LKALQDMSSTAPPAP HHHHHHHHCCCCCCC | 32.59 | 24759943 | |
301 | Phosphorylation | PPAPLQPSIRKAKTI CCCCCCCCCCCCCCC | 23.28 | 25159016 | |
307 | Phosphorylation | PSIRKAKTIPVQAFE CCCCCCCCCCEEEEE | 35.06 | 22817900 | |
332 | Ubiquitination | TKIGKSQKFTLSVDV EEECCCCCEEEEEEE | 47.62 | 22790023 | |
353 | Phosphorylation | LLRRQRDSQEDWTTF EEEECCCCCCCCCCC | 37.34 | 25338131 | |
426 | Phosphorylation | QDEPDMISVFIGTWN CCCCCCEEEEEEEEC | 12.34 | 22871156 | |
524 | Phosphorylation | PEHENRISHVSTSSV HHHCCCCCEECHHHC | 18.01 | 25777480 | |
527 | Phosphorylation | ENRISHVSTSSVKTG CCCCCEECHHHCHHC | 19.69 | 25777480 | |
528 | Phosphorylation | NRISHVSTSSVKTGI CCCCEECHHHCHHCC | 24.75 | 25777480 | |
529 | Phosphorylation | RISHVSTSSVKTGIA CCCEECHHHCHHCCC | 26.15 | 25777480 | |
530 | Phosphorylation | ISHVSTSSVKTGIAN CCEECHHHCHHCCCC | 27.93 | 25777480 | |
538 | Phosphorylation | VKTGIANTLGNKGAV CHHCCCCCCCCCCCE | 27.33 | 28833060 | |
662 | Phosphorylation | EISFPPTYRYERGSR HHCCCCCCCCCCCCC | 19.57 | 22817900 | |
671 | Phosphorylation | YERGSRDTYAWHKQK CCCCCCCCCCCCCCC | 17.65 | 25367039 | |
672 | Phosphorylation | ERGSRDTYAWHKQKP CCCCCCCCCCCCCCC | 16.39 | 22817900 | |
882 | Phosphorylation | VPTERLGTRERLYEW CCCCCCCCCHHHHHH | 33.67 | 29514104 | |
887 | Phosphorylation | LGTRERLYEWISIDK CCCCHHHHHHEECCC | 18.55 | 22499769 | |
891 | Phosphorylation | ERLYEWISIDKDDTG HHHHHHEECCCCCCC | 26.30 | 22499769 | |
897 | Phosphorylation | ISIDKDDTGAKSKVP EECCCCCCCCCCCCC | 49.53 | 25367039 | |
902 | Acetylation | DDTGAKSKVPSVSRG CCCCCCCCCCCCCCC | 58.41 | 19847677 | |
905 | Phosphorylation | GAKSKVPSVSRGSQE CCCCCCCCCCCCCCC | 35.39 | 22942356 | |
907 | Phosphorylation | KSKVPSVSRGSQEHR CCCCCCCCCCCCCCC | 34.95 | 29514104 | |
910 | Phosphorylation | VPSVSRGSQEHRSGS CCCCCCCCCCCCCCC | 31.14 | 29514104 | |
915 | Phosphorylation | RGSQEHRSGSRKPAS CCCCCCCCCCCCCCC | 42.92 | 29514104 | |
917 | Phosphorylation | SQEHRSGSRKPASTE CCCCCCCCCCCCCCC | 38.08 | 29514104 | |
922 | Phosphorylation | SGSRKPASTETSCPL CCCCCCCCCCCCCCH | 34.99 | 29514104 | |
925 | Phosphorylation | RKPASTETSCPLSKL CCCCCCCCCCCHHHH | 35.40 | 29514104 | |
926 | Phosphorylation | KPASTETSCPLSKLF CCCCCCCCCCHHHHC | 13.91 | 29514104 | |
927 | Glutathionylation | PASTETSCPLSKLFE CCCCCCCCCHHHHCC | 5.26 | 24333276 | |
964 | Phosphorylation | PLNPRLKSEGTSEQE CCCHHHCCCCCCCCC | 45.94 | 25367039 | |
967 | Phosphorylation | PRLKSEGTSEQEGVA HHHCCCCCCCCCCCC | 25.66 | 26026062 | |
968 | Phosphorylation | RLKSEGTSEQEGVAA HHCCCCCCCCCCCCC | 48.41 | 30635358 | |
981 | Phosphorylation | AAPPPKNSFNNPAYY CCCCCCCCCCCCCEE | 35.16 | 22499769 | |
987 | Phosphorylation | NSFNNPAYYVLEGVP CCCCCCCEEEECCCC | 8.72 | 26824392 | |
988 | Phosphorylation | SFNNPAYYVLEGVPH CCCCCCEEEECCCCC | 10.72 | 18515860 | |
1004 | Phosphorylation | LLPLEPPSLARAPLP CCCCCCCHHHCCCCC | 45.43 | 22499769 | |
1082 | Phosphorylation | MPVVRGRSGGEARGP CCEEECCCCCCCCCC | 54.71 | 27717184 | |
1104 | Phosphorylation | RPPLPPGTSPASTFL CCCCCCCCCCCHHHH | 36.99 | 29514104 | |
1130 | Phosphorylation | SVLQMAKTLSEVDYA HHHHHHHCHHHCCCC | 26.44 | 29514104 | |
1132 | Phosphorylation | LQMAKTLSEVDYAPG HHHHHCHHHCCCCCC | 40.58 | 22499769 | |
1136 | Phosphorylation | KTLSEVDYAPGPGRS HCHHHCCCCCCCCCC | 21.63 | 22499769 | |
1159 | Phosphorylation | LQPPRGPSDYGRPLS CCCCCCCCCCCCCCC | 46.41 | 29514104 | |
1161 | Phosphorylation | PPRGPSDYGRPLSFP CCCCCCCCCCCCCCC | 21.26 | 22817900 | |
1166 | Phosphorylation | SDYGRPLSFPPPRIR CCCCCCCCCCCHHHH | 38.09 | 26824392 | |
1175 | Phosphorylation | PPPRIRESIQEDLAE CCHHHHHHHHHHHHH | 21.52 | 25159016 | |
1193 | Phosphorylation | CPQGGRASGLGEAGM CCCCCCCCCCCCCHH | 32.94 | 24899341 | |
1252 | Phosphorylation | HKRLLLDTLQLSK-- HHHHHHHHHHCCC-- | 19.17 | 29514104 | |
1256 | Phosphorylation | LLDTLQLSK------ HHHHHHCCC------ | 24.29 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SHIP2_MOUSE !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SHIP2_MOUSE !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SHIP2_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
2AAA_MOUSE | Ppp2r1a | physical | 19825976 | |
SHC1_MOUSE | Shc1 | physical | 14502564 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...